×
BiomX Total Liabilities 2019-2024 | PHGE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
BiomX total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$199.1B
Stryker (SYK)
$138.5B
Boston Scientific (BSX)
$123.7B
Medtronic (MDT)
$116.1B
EssilorLuxottica (ESLOY)
$106.2B
Lonza Group Ag (LZAGY)
$44.7B
Haleon (HLN)
$44.4B
ResMed (RMD)
$35.7B
Terumo (TRUMY)
$28.9B
Koninklijke Philips (PHG)
$24.7B
Zimmer Biomet Holdings (ZBH)
$22.4B
Baxter (BAX)
$18.3B
Insulet (PODD)
$16.2B
Smith & Nephew SNATS (SNN)
$12.6B
Bio-Rad Laboratories (BIO)
$9.2B
BellRing Brands (BRBR)
$8.6B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$7.6B
ICU Medical (ICUI)
$4.3B
TG Therapeutics (TGTX)
$3.9B
Haemonetics (HAE)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Perrigo (PRGO)
$3.5B
Envista Holdings (NVST)
$3.3B
Neogen (NEOG)
$3.2B
GN Store Nord (GNNDY)
$2.9B
Agios Pharmaceuticals (AGIO)
$2.6B
QuidelOrtho (QDEL)
$2.6B
Green Thumb Industries (GTBIF)
$2.1B
LeMaitre Vascular (LMAT)
$2B
Stock Screener
Stock Research
Top Dividend Stocks
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
BiomX Total Liabilities 2019-2024 | PHGE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
BiomX total liabilities from 2019 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market Cap
Abbott Laboratories (ABT)
$199.1B
Stryker (SYK)
$138.5B
Boston Scientific (BSX)
$123.7B
Medtronic (MDT)
$116.1B
EssilorLuxottica (ESLOY)
$106.2B
Lonza Group Ag (LZAGY)
$44.7B
Haleon (HLN)
$44.4B
ResMed (RMD)
$35.7B
Terumo (TRUMY)
$28.9B
Koninklijke Philips (PHG)
$24.7B
Zimmer Biomet Holdings (ZBH)
$22.4B
Baxter (BAX)
$18.3B
Insulet (PODD)
$16.2B
Smith & Nephew SNATS (SNN)
$12.6B
Bio-Rad Laboratories (BIO)
$9.2B
BellRing Brands (BRBR)
$8.6B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$7.6B
ICU Medical (ICUI)
$4.3B
TG Therapeutics (TGTX)
$3.9B
Haemonetics (HAE)
$3.7B
Prestige Consumer Healthcare (PBH)
$3.6B
Perrigo (PRGO)
$3.5B
Envista Holdings (NVST)
$3.3B
Neogen (NEOG)
$3.2B
GN Store Nord (GNNDY)
$2.9B
Agios Pharmaceuticals (AGIO)
$2.6B
QuidelOrtho (QDEL)
$2.6B
Green Thumb Industries (GTBIF)
$2.1B
LeMaitre Vascular (LMAT)
$2B